Sensitivity analysis, Egger’s test, and the trim-and-fill method were performed for risk factors included in five or more studies, suggesting that high CRP, Ro-52 positivity, and MDA5 antibody levels are credible risk factors for RP-ILD in patients with IIM. The gene discussed is TRIM21; the disease is interstitial lung disease.